Brickell Biotech Inc (BBI)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

5777 CENTRAL AVENUE BOULDER, CO 80301

Vical Inc. researches and develops biopharmaceutical products based on the company's patented DNA delivery technologies. Products include DNA-based vaccines and therapeutics for the prevention or treatment of infectious diseases and cancer.

Data as of 2021-05-08 10:35:36 -0400
Market Cap63.108 Million Shares Outstanding66.93 Million Avg 30-day Volume1.332 Million
P/E Ratio-3.01765 Dividend Yield EPS-0.853
Price/Sales34.64 Debt to Equity1.24 EBITDA-20.966 Million
Price to Book Value2.33 Forward PE-2.12 Enterprise Value33.43 Million
Total Cash30.115 Million Current Debt6.353 Million Gross Profit1.822 Million
BETA0.8105 52-week High/Low2.61 / 0.466 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from BBI instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 29 22 31.82% 10 (0.6%) 7 (0.44%) 42.86%
13F shares: 5.638 Million 3.173 Million 77.71% 4.001 Million 2.322 Million 72.29%
% Ownership 10.5361 5.9286 77.72% 7.4759 4.3393 72.28%
New Positions: 11 5 120.0% 5 2 150.0%
Increased Positions 6 3 100.0% 3 1 200.0%
Closed Positions 3 7 -57.14% 2 2 0.0%
Reduced Positions 2 2 0.0% 1
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BBI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BBI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

85 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCAVOY DAVID R. GENERAL COUNSEL AND CCO

  • Officer
98,133 2021-03-16 4

BRETON JOSE CHIEF ACCOUNTING OFFICER

  • Officer
11,919 2021-03-16 2

SKLAWER ANDREW D COO AND SECRETARY

  • Officer
109,250 2021-03-16 3

CHADHA DEEPAK CHIEF RESEARCH & DEV. OFFICER

  • Officer
62,967 2021-03-16 3

BROWN ROBERT BUSARD CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
251,808 2021-03-15 3

SAMANT VIJAY B

  • Director
19,134 2020-12-31 5

LYONS GARY A

  • Director
18,762 2020-12-31 5

HARDY REGINALD L CHAIRMAN OF THE BOARD

  • Officer
  • Director
580,465 2020-12-31 5

MARCHIO ALBERT N II CHIEF FINANCIAL OFFICER

  • Officer
0 2020-12-01 1

VERU DENNISON T

  • Director
1,038,070 2020-09-15 4

LEVY ADAM SCOTT CHIEF BUSINESS OFFICER

0 2020-03-16 0

CARRUTHERS R MICHAEL CHIEF FINANCIAL OFFICER

0 2020-03-16 0

ABERCROMBIE GEORGE B CHIEF EXECUTIVE OFFICER

138,424 2020-02-14 0

AHUJA SANJEEV CHIEF MEDICAL OFFICER

0 2019-11-04 0

JU WILLIAM

13,363 2019-08-31 0

ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL MASTER FUND LTD.

BOYD STEVEN

  • 10% Owner
4,340,000 2019-01-10 0

DOUGLAS R GORDON

  • Director
0 2018-05-23 0

MERTON ROBERT C

  • Director
0 2018-05-23 0

MORROW GEORGE J

  • Director
0 2018-05-23 0

BELESON RICHARD M

  • Director
0 2018-05-23 0

SHENK THOMAS E

  • Director
0 2018-05-23 0

RAMOS ANTHONY ALAN VP, CHIEF FINANCIAL OFFICER

  • Officer
0 2018-01-08 0

SMITH LAWRENCE RUSSELL SR VP, RESEARCH

  • Officer
0 2018-01-08 0

MAMMEN MAMMEN SR VP, CLINICAL DEVELOPMENT

  • Officer
0 2018-01-08 0

ANGES MG, INC.

2,058,528 2016-08-02 0

BILINSKY IGOR SR VP, CORPORATE DEVELOPMENT

  • Officer
193,798 2015-07-13 0

SHERWIN STEPHEN A

  • Director
22,003 2015-05-21 0

SINGER JAMES R

  • 10% Owner
No longer subject to file 2013-09-12 0

ROLLAND ALAIN P PHD EXEC VP, PRODUCT DEVELOPMENT

  • Officer
No longer subject to file 2013-08-22 0

BROADFOOT JILL MARIE SR VICE PRESIDENT, CFO, SEC

  • Officer
No longer subject to file 2013-04-01 0

CAMPBELL ROBERT H

  • Director
14,328 2012-10-19 0

MARXE AUSTIN W & GREENHOUSE DAVID M

  • 10% Owner
No longer subject to file 2009-07-24 0

V-SCIENCES INVESTMENTS PTE LTD

TEMASEK LIFE SCIENCES PRIVATE LTD

FULLERTON MANAGEMENT PTE LTD

TEMASEK HOLDINGS (PRIVATE) LTD

  • 10% Owner
No longer subject to file 2009-05-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SKLAWER ANDREW D - Officer COO AND SECRETARY

2021-03-17 16:53:00 -0400 2021-03-16 M 20,000 a 116,250 direct 2.4194 -4.0323 -15.3226 5.6452 3 -33.7097 23

MCAVOY DAVID R. - Officer GENERAL COUNSEL AND CCO

2021-03-17 16:53:18 -0400 2021-03-16 M 25,000 d 0 direct

CHADHA DEEPAK - Officer CHIEF RESEARCH & DEV. OFFICER

2021-03-17 16:53:53 -0400 2021-03-16 M 25,000 d 0 direct

BRETON JOSE - Officer CHIEF ACCOUNTING OFFICER

2021-03-17 16:54:36 -0400 2021-03-16 M 15,000 d 0 direct

SKLAWER ANDREW D - Officer COO AND SECRETARY

2021-03-17 16:53:00 -0400 2021-03-16 M 20,000 d 0 direct

MCAVOY DAVID R. - Officer GENERAL COUNSEL AND CCO

2021-03-17 16:53:18 -0400 2021-03-16 F 8,750 $1.14 d 92,133 direct 2.4194 -4.0323 -15.3226 5.6452 3 -33.7097 23

CHADHA DEEPAK - Officer CHIEF RESEARCH & DEV. OFFICER

2021-03-17 16:53:53 -0400 2021-03-16 F 8,750 $1.14 d 62,967 direct 2.4194 -4.0323 -15.3226 5.6452 3 -33.7097 23

BRETON JOSE - Officer CHIEF ACCOUNTING OFFICER

2021-03-17 16:54:36 -0400 2021-03-16 F 5,250 $1.14 d 11,919 direct 2.4194 -4.0323 -15.3226 5.6452 3 -33.7097 23

SKLAWER ANDREW D - Officer COO AND SECRETARY

2021-03-17 16:53:00 -0400 2021-03-16 F 7,000 $1.14 d 109,250 direct 2.4194 -4.0323 -15.3226 5.6452 3 -33.7097 23

MCAVOY DAVID R. - Officer GENERAL COUNSEL AND CCO

2021-03-17 16:53:18 -0400 2021-03-16 M 25,000 a 100,883 direct 2.4194 -4.0323 -15.3226 5.6452 3 -33.7097 23

CHADHA DEEPAK - Officer CHIEF RESEARCH & DEV. OFFICER

2021-03-17 16:53:53 -0400 2021-03-16 M 25,000 a 71,717 direct 2.4194 -4.0323 -15.3226 5.6452 3 -33.7097 23

BRETON JOSE - Officer CHIEF ACCOUNTING OFFICER

2021-03-17 16:54:36 -0400 2021-03-16 M 15,000 a 17,169 direct 2.4194 -4.0323 -15.3226 5.6452 3 -33.7097 23

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BRICKELL BIOTECH INC BBI 2021-05-14 22:15:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 21:45:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 21:15:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 20:45:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 20:15:04 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 19:45:02 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 19:15:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 18:45:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 18:15:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 17:45:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 17:15:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 16:45:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 16:15:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 15:45:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 15:15:02 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 14:45:04 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 14:15:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 13:45:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 13:15:03 UTC -22.5121 22.5621 1000000
BRICKELL BIOTECH INC BBI 2021-05-14 12:45:03 UTC -22.5121 22.5621 1000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments